Screening of selective histone deacetylase inhibitors by proteochemometric modeling

<p>Abstract</p> <p>Background</p> <p>Histone deacetylase (HDAC) is a novel target for the treatment of cancer and it can be classified into three classes, i.e., classes I, II, and IV. The inhibitors selectively targeting individual HDAC have been proved to be the better...

詳細記述

書誌詳細
出版年:BMC Bioinformatics
主要な著者: Wu Dingfeng, Huang Qi, Zhang Yida, Zhang Qingchen, Liu Qi, Gao Jun, Cao Zhiwei, Zhu Ruixin
フォーマット: 論文
言語:英語
出版事項: BMC 2012-08-01
主題:
オンライン・アクセス:http://www.biomedcentral.com/1471-2105/13/212

類似資料